Unique ID issued by UMIN | UMIN000000649 |
---|---|
Receipt number | R000000713 |
Scientific Title | Treatment of bone diseases with porous ceramics integrated with autologous bone marrow derived mesenchymal cells |
Date of disclosure of the study information | 2007/04/01 |
Last modified on | 2012/03/23 17:59:20 |
Treatment of bone diseases with porous ceramics integrated with autologous bone marrow derived mesenchymal cells
Porous ceramics with autologous mesenchymal cells for bone diseases(MCTRP0301)
Treatment of bone diseases with porous ceramics integrated with autologous bone marrow derived mesenchymal cells
Porous ceramics with autologous mesenchymal cells for bone diseases(MCTRP0301)
Japan |
massive bone defects, fracture non-union
Orthopedics |
Others
NO
To evaluate the safety and efficacy of the treatment of bone defects with interconnected-porous ceramics integrated with autologous bone marrow derived mesenchymal cells for the patients with benign bone tumors or tumor-like conditions of bone
Safety,Efficacy
Exploratory
Explanatory
Phase I,II
Periodical evaluation of osseous integration by plain X-ray (radiographic evaluation for ceramic bone substitute proposed by Myoui, et al.) Adverse events (National Cancer Institute Common Toxicity Criteria Ver. 2, Japanese version, JCOG version)
Overall judgment by multimodal imaging, quantitative radiopacity by aluminum step, BMD by DEXA, histological evaluation, functional evaluation, QOL assessment by SF-36
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment | Maneuver |
Mesenchymal stem cells that are culture-expanded from bone marrow aspirates are integrated to interconnected porous ceramics and osteoblastic differentiation is induced to generate "cultured bone" - a living bone substitute. The cultured bone is implanted to bone void after the removal of bone tumor.
20 | years-old | <= |
70 | years-old | > |
Male and Female
Patients with benign bone tumors or tumor-like conditions of bone
Active local infection
Serious complications including malignancies
Diabetes
Dialysis for renal failure
Under the influence of steroids or other drugs that affect bone metabolism
Infectious diseases (HIV, HBV, HCV, HTLV, syphilis)
Pregnancy
10
1st name | |
Middle name | |
Last name | Hideki Yoshikawa |
Osaka University Graduate School of Medicine
Department of Orthopedics
2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-3552
1st name | |
Middle name | |
Last name | Akira Myoui |
Osaka University Hospital
Medical Center for Translational Research
2-15 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-6551
Osaka University Graduate School of Medicine, Department of Orthopedics
None
Self funding
Osaka University Hospital, Medical Center for Translational Research
National Institute of Advanced Industrial Science and Technology, Research Institute for Cell Engineering
NO
2007 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2003 | Year | 08 | Month | 25 | Day |
2004 | Year | 06 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
2007 | Year | 03 | Month | 22 | Day |
2012 | Year | 03 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000713
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |